Hangzhou Tigermed Consulting Co., Ltd.
Hangzhou Tigermed Consulting Co., Ltd.
Your view on HNGZY
Overview
What the company does, where it operates, and who runs it.
About Hangzhou Tigermed Consulting Co., Ltd.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Xiaoping Ye D.Phil
- Headquarters
- F18, Building A – Shengda Science Park, Hangzhou, CN
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Xiaoping Ye D.Phil
- Headquarters
- F18, Building A – Shengda Science Park, Hangzhou, CN
Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments.
The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system.
It also provides biometrics services comprising data management, biostatistics, and statistical programming; and integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital.
Further, the company offers medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value-added services; and post-marketing study, real world evidence, and vaccine clinical trial services.
Hangzhou Tigermed Consulting Co., Ltd. was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Hangzhou Tigermed Consulting Co., Ltd., and the rating behind it. HNGZY last traded at $4.00, 660.0× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Hangzhou Tigermed Consulting Co., Ltd.. Starting points for Hangzhou Tigermed Consulting Co., Ltd.: P/E 660.0, EPS $0.11, beta 0.70 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Hangzhou Tigermed Consulting Co., Ltd.. Hangzhou Tigermed Consulting Co., Ltd. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Hangzhou Tigermed Consulting Co., Ltd.. Trailing twelve-month EPS for Hangzhou Tigermed Consulting Co., Ltd. stands at $0.11. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Hangzhou Tigermed Consulting Co., Ltd.. Hangzhou Tigermed Consulting Co., Ltd. has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Hangzhou Tigermed Consulting Co., Ltd. valued side by side against its closest peers. Hangzhou Tigermed Consulting Co., Ltd. is measured against Biotechnology peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Hangzhou Tigermed Consulting Co., Ltd., and how their positions are changing. At a $6.16B market value, institutional positions materially move Hangzhou Tigermed Consulting Co., Ltd.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Hangzhou Tigermed Consulting Co., Ltd. executives and directors. Shares of Hangzhou Tigermed Consulting Co., Ltd. have traded between $4.00 and $4.28 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Hangzhou Tigermed Consulting Co., Ltd.. Hangzhou Tigermed Consulting Co., Ltd. is a $6.16B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Hangzhou Tigermed Consulting Co., Ltd.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Hangzhou Tigermed Consulting Co., Ltd.. Coverage tracks Hangzhou Tigermed Consulting Co., Ltd. within Biotechnology (Healthcare). Press releases and market coverage, newest first.